>>After going on another thread and posting what I thought was an interesting take on the tough market enviroment that the company would be facing in the future, I received death threats and had it confirmed numerous times what my wife has been telling me for over 20 years is really the truth. That being I am a worthless no good liar, an idiot, and will never make it in life. <<
Well, maybe your wife is right. After all, you sold your LGND. That seems to confirm the analysis. (:>) Would you sight the posts for me? I"ll check it out. You should remember if you go onto a thread of a stock which has taken quite a dive and where people have lost a lot of money, and then explain to them why the stock will continue to do poorly in the future, then you will probably get a nasty reaction.
>> In addition, I had been seen in a sheep field not counting sheep.<<
Death threats are one thing, but that is really in poor taste, especially for a Texan. Everyone knows Texans prefer longhorns. (:>)
>>Now that I've said it, please understand that even though I have the word Texas in my name, I actually live in Boulder, Colorado and I go for walks each day in the mountains, I sleep late on many occasions, and my heart is in Hawaii with my dog, Dogface.<<
Now, TD, are you making fun of me? You'd never catch me in a sheep field, nor do I have any inclinations in regard to dogface (small d). I'm a plant lover myself, although I do have a great fondness for cats.
As for Millenium, I haven't looked closely at them. Does sound like a lot of money coming in IF they meet their milestones--what sorts of royalties are they getting? As to their share price, that is irrelevant without knowing their market cap. How many shares do they have outstanding?
We do have very high expectations in regard to LGND. And I think many of us were disappointed that we did not go a lot higher with the LLY diabetes deal. But there is a lot of good news to come over the next few months, although we may have been robbed of the P2 diabetes news. I suggest you wait until the end of January to reevaluate. By then much of the news should be out, all the bio conferences will be over and we should have all the upgrades that may be coming in the near future. LGND is still a development stage biotech with the many attendant risks. Although it is a lot less risky now than a year ago. So, one should be well diversified. |
